Baseline clinical characteristics and patient profile of the TURKMI registry: Results of a nation-wide acute myocardial infarction registry in Turkey
| العنوان: | Baseline clinical characteristics and patient profile of the TURKMI registry: Results of a nation-wide acute myocardial infarction registry in Turkey |
|---|---|
| المؤلفون: | Erol, M.K., Kayıkçıoğlu, M., Kılıçkap, M., Arın, C.B., Kurt, İ.H., Aktaş, İ., Güneş, Y., Özkan, E., Şen, T., İnce, O., Örnek, E., Asoğlu, R., Aladağ, N., Zeybey, U., Sinan, Ü.Y., Dural, M., Tüner, H., Doğan, A.C., Yenerçağ, M., Akboğa, M.K., Deveci, O.S., Somuncu, M.U., Inanir, M., Yalçin, O.Y., Genc, O., Yildirim, A., Asoglu, R., Inci, S., Ornek, E., Cetin, M., Kiziltunc, E., Yayla, C., Ertem, A.G., Akboga, M.K., Genc, A., Oztekin, G.M.Y., Gitmez, M., Tuncay, B., Can, V., Ari, H., Tatar, F.P., Gazi, E., Yeşildas, C., Er, O., Ozturk, O., Candemir, A., Kayikçioglu, M., Yavuzgil, O., Mirzaoğlu, C., Bakirci, E.M., Degirmenci, H., Besli, F., Ince, O., Hancıoglu, E., Akurk, I.F., Oflar, E., Çaglar, N.T., Halac, H.A.Y., Kalyoncuoglu, M., Balaban, I., Karatas, M., Kirma, C., Guler, A., Can, C., Dogan, A.C., Yalcin, A.A., Arin, C.B., Sinan, U.Y., Kücükokur, M., Ozdogan, O., Aksu, E., Günes, H., Simsek, Z., Ozkan, E., Sabanoğlu, C., Celik, Y., Sen, T., Astarcıoglu, M.A., Aktas, I., Gozubuyuk, G., Tigen, M.K., Sunbul, M., Arslan, A., Celik, A., Akkus, O., Alsancak, Y., Mert, K.U., Kose, N., Kılıç, İsmail Doğu, Emlek, N., Kocayigit, I., Yanik, A., Yenerçag, M., Çitrakoglu, O.F., Dursun, I., Altay, S., Baysal, S.S., Aladag, N., Sarikaya, R., Duz, R., Tuncer, M., Tuner, H., Ungan, I., Karaduman, B.D., Bozkurt, E., TURKMI study group |
| المساهمون: | Ege Üniversitesi, Tıp Fakültesi |
| المصدر: | Anatolian Journal of Cardiology, Vol 24, Iss 1, Pp 43-53 (2020) Anatolian Journal of Cardiology |
| بيانات النشر: | Turkish Society of Cardiology, 2020. |
| سنة النشر: | 2020 |
| مصطلحات موضوعية: | Male, lcsh:Diseases of the circulatory (Cardiovascular) system, Turkey, medicine.medical_treatment, Myocardial Infarction, Angiotensin-Converting Enzyme Inhibitors, 030204 cardiovascular system & hematology, Coronary Angiography, Coronary artery disease, 0302 clinical medicine, Ischemia, Risk Factors, Registries, 030212 general & internal medicine, Myocardial infarction, Original Investigation, Aspirin, education.field_of_study, biology, ST elevation, Smoking, Age Factors, Middle Aged, Hypertension, Population study, Female, Cardiology and Cardiovascular Medicine, medicine.drug, medicine.medical_specialty, Registry, Adrenergic beta-Antagonists, Hypercholesterolemia, Population, Hyperlipidemias, Acute myocardial infarction, 0-Belirlenecek, Angiotensin Receptor Antagonists, 03 medical and health sciences, Percutaneous Coronary Intervention, Fibrinolytic Agents, Internal medicine, Diabetes mellitus, medicine, Humans, education, Aged, business.industry, Percutaneous coronary intervention, Angiotensin-converting enzyme, medicine.disease, lcsh:RC666-701, biology.protein, business, Platelet Aggregation Inhibitors |
| الوصف: | Objective: The TURKMI registry is designed to provide insight into the characteristics, management from symptom onset to hospital discharge, and outcome of patients with acute myocardial infarction (MI) in Turkey. We report the baseline and clinical characteristics of the TURKMI population. Methods: The TURKMI study is a nation-wide registry that was conducted in 50 centers capable of percutaneous coronary intervention selected from each EuroStat NUTS region in Turkey according to population sampling weight, prioritized by the number of hospitals in each region. All consecutive patients with acute MI admitted to coronary care units within 48 hours of symptom onset were prospectively enrolled during a predefined 2-week period between November 1, 2018 and November 16, 2018. Results: A total of 1930 consecutive patients (mean age, 62.0 +/- 13.2 years; 26.1% female) with a diagnosis of acute MI were prospectively enrolled. More than half of the patients were diagnosed with non-ST elevation MI (61.9%), and 38.1% were diagnosed with ST elevation MI. Coronary angiography was performed in 93.7% and, percutaneous coronary intervention was performed in 73.2% of the study population. Fibrinolytic therapy was administered to 13 patients (0.018%). Aspirin was prescribed in 99.3% of the patients, and 94% were on dual antiplatelet therapy at the time of discharge. Beta blockers were prescribed in 85.0%, anti-lipid drugs in 96.3%, angiotensin converting enzyme inhibitors in 58.4%, and angiotensin receptor blockers in 7.9%. Comparison with European countries revealed that TURKMI patients experienced MI at younger ages compared with patients in France, Switzerland, and the United Kingdom. The most prevalent risk factors in the TURKMI population were hypercholesterolemia (60.2%), hypertension (49.5%), smoking (48.8%), and diabetes (37.9%). Conclusion: The nation-wide TURKMI registry revealed that hypercholesterolemia, hypertension, and smoking were the most prevalent risk factors. TURKMI patients were younger compared with patients in European Countries. The TURKMI registry also confirmed that current treatment guidelines are largely adopted into clinical cardiology practice in Turkey in terms of antiplatelet, anti-ischemic, and anti-lipid therapy. Turkish Society of Cardiology; Astra-Zeneca CompanyAstraZeneca TURKMI is an investigator-initiated study sponsored by the Turkish Society of Cardiology that receives major funding from Astra-Zeneca Company for this project. |
| وصف الملف: | application/pdf |
| اللغة: | English |
| الوصول الحر: | https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d64bdb19e19bf479609138eca712c415Test https://hdl.handle.net/11499/37106Test |
| حقوق: | OPEN |
| رقم الانضمام: | edsair.doi.dedup.....d64bdb19e19bf479609138eca712c415 |
| قاعدة البيانات: | OpenAIRE |
| الوصف غير متاح. |